Login / Signup

Gold Coast criteria expand clinical trial eligibility in amyotrophic lateral sclerosis.

Gordon A E JewettShahin KhayambashiGeoffrey S FrostBenjamin BelandAngela LeeVictoria L HodgkinsonLawrence KorngutSameer Chhibber
Published in: Muscle & nerve (2022)
Until robust biomarkers are available to diagnose ALS, consensus diagnostic criteria remain necessary. Gold Coast criteria would expand research and clinical trial eligibility and improve external validity of clinical trial results.
Keyphrases
  • clinical trial
  • phase ii
  • open label
  • double blind
  • study protocol
  • phase iii
  • silver nanoparticles